Istvan Petak’s overview of AI in cancer research at the Budapest IT Fest

Istvan Petak shared on LinkedIn:

“Hello Budapest, Hello IT Fest// Business Fest. Computational technologies and artificial intelligence have so much potential in healthcare, particularly in our fight against cancer. AI can improve diagnostics during endoscopy, radiology, and histology, help us discover new drug targets, develop new therapies, and improve personalized treatment decisions. I was honored to give an overview of AI in cancer research at the Budapest IT Fest. IT companies and innovative start-ups play a pivotal role in developing the next generation of healthcare solutions leveraging the advancement of computer and data sciences. Thank you, Monika Weber, for the many excellent photos I could choose from.”

Source: Istvan Petak/LinkedIn

Dr. Istvan Petak specialises in precision oncology and molecular pharmacology of targeted therapies. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC).